FDA approves painkiller designed to eliminate risks of addiction associated with opioids
The Future of Pain Management: Steering Clear of Opioids The landscape of pain management is shifting dramatically, with Vertex Pharmaceuticals leading the charge with its latest FDA-approved pain drug, Journavx. This innovation marks a broader industry trend towards developing non-opioid solutions due to the significant risks associated with opioid addiction and overdose. A Leap into … Read more